Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 17Phase 3 7Phase 1/2 4Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 11Completed 7Active not recruiting 6Withdrawn 2Terminated 2Not yet recruiting 2

Sponsor Class

INDUSTRY 7

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7Endocrine 1

Conditions

Breast Neoplasms 6Osteitis Deformans 1Neoplasms by Site 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hereditary Sensory and Autonomic Neuropathies 1Breast Diseases 1Advanced Metastatic Breast Cancer 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Completed × ribociclib × Clear all
NCT01958021 2025-03-07

MONALEESA-2

Novartis

Phase 3 Completed
668 enrolled 15 charts
Breast

Breast Neoplasms

NCT03439046 2024-08-01

BioItaLEE

Novartis

Phase 3 Completed
287 enrolled
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT02278120 2024-03-12

MONALEESA-7

Novartis

Phase 3 Completed
672 enrolled 16 charts 1 FDA
Breast

Advanced Metastatic Breast Cancer

NCT02422615 2023-11-30

MONALEESA-3

Novartis

Phase 3 Completed
726 enrolled 17 charts 1 FDA
BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

NCT02941926 2023-10-24

COMPLEEMENT-1

Novartis

Phase 3 Completed
3,246 enrolled 11 charts
Breast

Breast Neoplasms

NCT03462251 2023-01-19

RIBBIT

iOMEDICO AG

Phase 3 Completed
41 enrolled
Breast

Breast Neoplasms

NCT03096847 2021-10-11

Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

Novartis

Phase 3 Completed
502 enrolled 20 charts
Breast

Breast Neoplasms, Osteitis Deformans

Data powered by HemOnc (CC BY 4.0) Colophon âš¡